Explore our news page for thought leadership articles, technical expertise and the latest developments in the world of innovation funding.
Filter
This article focuses on a critical avenue available to MedTech SMEs for driving growth - the strategic utilisation of Research and Development Tax Credits.
Hooke Biotechnology have secured €5.5m in blended finance from the highly competitive Horizon Europe EIC Accelerator to develop Mera.
UK registered SMEs can apply for a share of up to £25 million to develop innovative solutions to health and healthcare challenges. This funding is from Innovate UK.
UK registered SMEs can apply for a share of up to £25 million to develop innovative solutions to health and healthcare challenges. This funding is from Innovate UK.
Written for our partners Technology Dispatch. The healthcare sector is incredibly diverse and packed with innovative thinkers. It’s also a hotbed for research and development, constantly pioneering disruptive new technologies, equipment and treatments.
The Grants team at Myriad Associates are proud to announce that they have secured over €30m from the Disruptive Technologies Innovation Fund (DTIF).
Myriad Associates managed to grow by 20% and break the £2million turnover barrier during a turbulent year. Our CEO reveals the secret behind Myriad Associates success.
After an incredibly tough year filled with uncertainty and worry, Myriad Associates are pleased to welcome three new additions to the team!
With a cool 70 robots now working within our healthcare sector, we take a closer look at what amazing technologies are on the way.
The Life Sciences sector covers everything from pharmaceuticals and disease research to plant life, biological resources and much more.
Onkimmune was founded in 2015 with the goal of developing novel anti-cancer therapies using Natural Killer (NK) cells.
Myriad Associates is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.